Top Markets
#1 Black Phoenix Black Phoenix +854.30%
#2 Nesa Nesa +532.32%
#3 QuantixAI QuantixAI +102.94%
#4 MetaDAO MetaDAO +29.20%
#5 Ontology Gas Ontology Gas +26.94%
#6 Bedrock Bedrock +18.99%
#7 Status Status +15.26%
#8 Humanity Humanity +14.32%
#9 Stacks Stacks +13.76%
#10 peaq peaq +13.75%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
ShockWave Medical, Inc. ShockWave Medical, Inc.

ShockWave Medical, Inc.

SWAV
Rank in Stocks #1815
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Share Price
$334.75
Last synced: 2024-05-30
Market Cap
$12.46B
Change (1 day)
-0.02%
Change (1 year)
0.00%
Country
US
Trade ShockWave Medical, Inc. (SWAV)

Category

Healthcare
P/E ratio for ShockWave Medical, Inc. (SWAV)
P/E ratio as of August 2026 TTM: 83.48
According to ShockWave Medical, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 83.48. At the end of 2022 the company had a P/E ratio of 34.17.
P/E ratio history for ShockWave Medical, Inc. from 2017 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 83.48 75.78%
2023 47.49 38.97%
2022 34.17 -104.99%
2021 -685.10 1,211.53%
2020 -52.24 154.29%
2019 -20.54 2.89%
2018 -19.97 2.63%
2017 -19.45 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -57.14%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -58.24%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -74.38%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -74.96%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.